A Case Report of Community Acquired Pneumonia Due to Multi-drug Resistance Pseudomonas aeruginosa Treated with Elores

Community-acquired pneumonia (CAP) is a common and potentially serious illness associated with considerable morbidity and mortality, particularly in patients infected with Multidrug resistance (MDR) Gram-negative bacilli. After S. pneumoniae, Pseudomonas aeruginosa is the second most common pneumonia causing pathogen followed by K. pneumoniae and S. aureus in India. An alarming rise in the incidence of bacteria resistant even to last resort of antibiotics in recent years, forced clinicians to change antibiotic treatment options in pneumonia. Here we discuss a case of CAP infected with MDR Pseudomonas aeruginosa which is resistant to carbapenems and successfully treated with a new antibiotic adjuvant entity (AAE); ELORES (Ceftriaxone + Sulbactam with adjuvant Disodium edetate).